ATE432063T1 - Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft - Google Patents

Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft

Info

Publication number
ATE432063T1
ATE432063T1 AT01918930T AT01918930T ATE432063T1 AT E432063 T1 ATE432063 T1 AT E432063T1 AT 01918930 T AT01918930 T AT 01918930T AT 01918930 T AT01918930 T AT 01918930T AT E432063 T1 ATE432063 T1 AT E432063T1
Authority
AT
Austria
Prior art keywords
physiologically active
high pressure
active substances
dispersions containing
containing physiologically
Prior art date
Application number
AT01918930T
Other languages
English (en)
Inventor
James Wilmott
Original Assignee
Basf Catalysts Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Catalysts Llc filed Critical Basf Catalysts Llc
Application granted granted Critical
Publication of ATE432063T1 publication Critical patent/ATE432063T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Colloid Chemistry (AREA)
AT01918930T 2000-03-23 2001-03-23 Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft ATE432063T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19150800P 2000-03-23 2000-03-23
PCT/US2001/009272 WO2001070197A2 (en) 2000-03-23 2001-03-23 Method for preparing high pressure/high shear dispersions containing physiologically active ingredients

Publications (1)

Publication Number Publication Date
ATE432063T1 true ATE432063T1 (de) 2009-06-15

Family

ID=22705764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918930T ATE432063T1 (de) 2000-03-23 2001-03-23 Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft

Country Status (9)

Country Link
EP (1) EP1267830B1 (de)
JP (1) JP2003527411A (de)
AT (1) ATE432063T1 (de)
AU (1) AU2001245947A1 (de)
CA (1) CA2403704C (de)
DE (1) DE60138804D1 (de)
ES (1) ES2327901T3 (de)
MX (1) MXPA02009275A (de)
WO (1) WO2001070197A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US6783766B2 (en) 2002-03-06 2004-08-31 Dow Global Technologies Inc. Process for preparing a cosmetic formulation
BRPI0613631A8 (pt) * 2005-07-18 2017-12-26 Univ Massachusetts Lowell nanoemulsão e método,
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CN101848702B (zh) 2006-12-01 2013-07-17 安特里奥公司 两亲实体纳米粒子
KR101518077B1 (ko) 2006-12-01 2015-05-28 안테리오스, 인코퍼레이티드 펩티드 나노입자 및 이의 용도
US20080206351A1 (en) * 2007-02-23 2008-08-28 Conopco, Inc., D/B/A Unilever Malodor Reduction of Cosmetic Products
ES2660906T3 (es) 2007-05-31 2018-03-26 Anterios, Inc. Nanopartículas de ácido nucleico y usos de las mismas
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
DE102011117364A1 (de) * 2011-10-29 2013-05-02 Merck Patent Gmbh Hautaufheller in der Phototherapie
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
CN109310646A (zh) 2016-05-05 2019-02-05 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
CN110225975A (zh) 2016-08-23 2019-09-10 阿库斯股份有限公司 用于治疗人受试者中非年龄相关的听力损害的组合物和方法
JP2019535829A (ja) 2016-11-21 2019-12-12 エイリオン セラピューティクス， インコーポレイテッド 大型薬剤の経皮送達
CA3047424A1 (en) 2016-12-22 2018-06-28 Unilever Plc Stabilization of cosmetic compositions comprising fish oils and hydroxylated fatty acids and/or its derivatives
WO2021168362A1 (en) 2020-02-21 2021-08-26 Akouos, Inc. Compositions and methods for treating non-age-associated hearing impairment in a human subject

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5916596A (en) * 1993-02-22 1999-06-29 Vivorx Pharmaceuticals, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
DE4440337A1 (de) * 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5914102A (en) * 1997-11-26 1999-06-22 Schering-Plough Healthcare Products, Inc. High SPF perspiration-resistant sunscreen
CA2366458A1 (en) * 2000-01-31 2001-08-16 Collaborative Technologies, Inc. Method and system for producing customized cosmetic and pharmaceutical formulations on demand

Also Published As

Publication number Publication date
CA2403704A1 (en) 2001-09-27
WO2001070197A2 (en) 2001-09-27
AU2001245947A1 (en) 2001-10-03
CA2403704C (en) 2012-04-10
JP2003527411A (ja) 2003-09-16
EP1267830B1 (de) 2009-05-27
ES2327901T3 (es) 2009-11-05
EP1267830A2 (de) 2003-01-02
MXPA02009275A (es) 2004-09-06
DE60138804D1 (de) 2009-07-09
WO2001070197A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
ATE432063T1 (de) Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft
DE59909181D1 (de) Verfahren zur herstellung farbstoffenthaltender, wässriger polymerisatdispersionen
ATE261337T1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikro- und nanopartikeln mittels eines mikromischers
ATE246880T1 (de) Verfahren zur herstellung von phytosterol- oder phytostanol-mikropartikeln
DE60205047D1 (de) Poröse Teilchen, wässrige Dispersionen und Verfahren zu ihrer Herstellung
EP1149841A3 (de) Verfahren zur Herstellung von 6B,7B;15B,16B-dimethylene-5B-hydroxy-3-oxo-17alpha-androstane-21,17-carbolactone
AU2003251349A1 (en) Porous beads and method of production thereof
ATE409023T1 (de) Wirkstoffverabreichungssysteme mit verzögerter freisetzung, verwendung und verfahren zur herstellung derselben
AU3212201A (en) Method
DE122007000082I1 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
ATE278390T1 (de) Verfahren zur herstellung von arzneistoffpartikeln
ATE407664T1 (de) Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben.
ATE448221T1 (de) Verfahren zur herstellung von 1,3,4,5-tetrahydro- 2h-3-benzazepin-2-on-derivaten und dessen anwendung in der herstellung von ivabradin sowie dessen pharmazeutisch verträglichen salze
ATE497509T1 (de) Elektrosterisch stabilisierte wässrige polyurethan-harze, verfahren zu ihrer herstellung und deren verwendung
ATE334682T1 (de) Verfahren zur herstellung von den trans-4-n- butylcyclohexanoicsaüre- und undecanoicsaüreestern von (7-alpha,11-beta)- dimethyl-17 beta -hydroxy-4-estren-3-one und deren medizynische anwendung
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
ATE308525T1 (de) Hydantoin-, thiohydantoin-, pyrimidinedion- und thioxopyrimidinon-derivate, verfahren zur ihrer herstellung und ihre anwendung als arztneimittel
DE60143261D1 (de) Hämatologie-blutkontrolle und verfahren zu ihrer herstellung
TW200611711A (en) Cosmetic treatment system and methods
DE50103988D1 (de) Verfahren zur herstellung von hohlkörperelementen, hohlkörperelement, zusammenbauteil und matrize
ATE380191T1 (de) Gemischtes olanzapinsolvat, verfahren zu dessen herstellung und verfahren zur herstellung von olanzapin-form i daraus
DE59800058D1 (de) Karosseriehohlträger, sowie Verfahren zur dessen Herstellung mittels Innenhochdruck
DE60234430D1 (de) Halbdurchlässige verbundmembran, verfahren zur herstellung derselben und verfahren zur wasserbehandlung unter verwendung derselben
ATE305918T1 (de) Verfahren zur herstellung von organischen polyisocyanaten
ATE418642T1 (de) Verfahren zur herstellung eines einbügelbaren einlagestoffs, sowie dadurch hergestellter einlagestoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties